Estrogens
Estradiol
Estradiol, the principal human estrogen, is labeled mainly for symptoms of menopause and sold as generic tablets, skin patches, gels and a spray, and vaginal creams, inserts and rings. Most estradiol labels still carry a boxed warning on endometrial cancer, stroke, blood clots and heart attack, breast cancer and probable dementia, but in February 2026 the FDA narrowed Divigel’s box to endometrial cancer and removed the boxes from Estring and Bijuva.
This page is general information about a medication and how cash prices for it are set. It is not medical advice and does not replace the label, your prescriber or your pharmacist. How we handle medical information
Tablets are sold only as generics; Estrace 1 and 2 mg tablets are listed as discontinued and DailyMed has no Estrace tablet label. Rated generics are sold for Climara, Vivelle-Dot, Minivelle, Divigel, EstroGel, Estrace cream, Vagifem and Imvexxy; Menostar, Elestrin, Evamist, Estring and Femring have none, and the Alora patch is discontinued.
About Estradiol
Generic tablets are labeled for moderate to severe hot flashes and vaginal symptoms of menopause, low estrogen from hypogonadism, castration or primary ovarian failure, prevention of postmenopausal osteoporosis, and palliation of some metastatic breast cancers and advanced prostate cancer. Climara and Vivelle-Dot patches share the menopause, low estrogen and osteoporosis uses, and Menostar is labeled only to prevent postmenopausal osteoporosis; Divigel, Elestrin and the Evamist spray treat hot flashes, and EstroGel vaginal symptoms too; vaginal creams, inserts and Estring treat vaginal and vulvar symptoms of menopause, and Femring hot flashes too. Treatment starts at a low dose and is adjusted to symptoms; for a woman with a uterus, adding a progestogen lowers the risk of endometrial cancer.
Most estradiol labels carry a boxed warning in four parts: endometrial cancer in a woman with a uterus using estrogen alone; stroke and blood clots, and with a progestin heart attack too, in the Women’s Health Initiative study; probable dementia in women 65 and older; and invasive breast cancer with estrogen plus a progestin. Those boxes say estrogens are not for preventing heart disease or dementia, and the labels call for the lowest effective dose for the shortest duration. Estradiol is not used with unexplained genital bleeding, breast cancer or another estrogen-dependent cancer, blood clots in the legs or lungs, a stroke or heart attack, liver disease or pregnancy. Other warnings include gallbladder disease, high blood pressure, raised triglycerides and worsening hypothyroidism; abnormal uterine bleeding and breast tenderness were common side effects in the Divigel trial.
In November 2025 the FDA began removing the boxed warning statements on cardiovascular disease, breast cancer and probable dementia from menopausal hormone therapy labels, keeping the endometrial cancer warning for systemic estrogen-alone products, and on February 12, 2026 it approved the first six revised labels. Three are estradiol products: Divigel’s box now covers only endometrial cancer in women with a uterus, and its label suggests considering it for women under 60 or within 10 years of menopause; Estring and Bijuva (estradiol with progesterone) have no boxed warning. The other estradiol labels checked in October 2026, including generic tablets, Climara, Menostar, Vivelle-Dot, EstroGel, Elestrin, Evamist, Estrace cream, Vagifem and Femring, still carry the full warning; Evamist’s adds that children have had breast budding and breast masses after contact with treated skin.
Taking Estradiol
- How to take it
- Tablets once a day, with or without food, as scheduled. Patches go on clean, dry skin of the lower abdomen or, for some brands, the buttocks, never the breasts, once or twice a week by brand, at a new site each time; gels are applied once a day where the label directs and left to dry. Vaginal inserts are usually used daily for 2 weeks, then twice a week; Estring and Femring stay in for three months.
- If you miss a dose
- Tablets and vaginal doses: use it when you remember unless the next is nearly due, and never double up. Put on a missed patch when you remember and keep your usual change days; apply a missed gel dose only if the next is more than 12 hours away, and never use the spray more than once a day.
- Storage
- At room temperature, out of reach of children; keep patches sealed in their pouches until use and gels and the spray away from flames until dry, and fold used patches in half, sticky sides together, before disposal.
- Interactions to know about
- St. John’s wort, phenobarbital, carbamazepine and rifampin may lower estrogen levels; erythromycin, clarithromycin, ketoconazole, itraconazole, ritonavir and grapefruit juice may raise them. Women taking thyroid hormone may need a higher thyroid dose.
This summarizes the official prescribing information. Your prescriber’s and pharmacist’s instructions, and the leaflet that comes with your medicine, take priority.
Why the cash price for Estradiol differs from pharmacy to pharmacy
A pharmacist can substitute only a generic rated equivalent to the exact product prescribed. Generic patches are rated against a particular brand, so a weekly patch cannot replace a twice-weekly one, and no form can be exchanged for another.
Menostar, Elestrin, Evamist, Estring and Femring have no rated generic, so every quote for them is for the brand.
Upload it and licensed pharmacies reply with their own cash price. You pay the pharmacy, not us.
Ways to pay less for Estradiol without insurance
- Ask for a rated generic of the exact form prescribed, and check that the prescription does not block substitution.
- If Menostar, Elestrin, Evamist, Estring or Femring is prescribed, ask the prescriber whether a form with generics would suit you, or ask the maker whether a savings program applies to someone paying cash.
- Once your dose is settled, ask for a ninety-day supply, and compare more than one pharmacy.
- Upload the prescription to Script Unlock so licensed pharmacies can quote their cash price. You pay the pharmacy directly.
How Script Unlock gets you a cash price for Estradiol
Prices on this site come from pharmacies responding to a real prescription. We do not publish estimated, average or "typical" prices, because none of those would be your price.
- 1You upload your prescription
A photo of your Estradiol prescription is enough. Nothing is sold on the site; you are asking pharmacies to quote.
- 2Licensed pharmacies respond
Pharmacies that Script Unlock has verified see the request and each can reply with its own cash price for your exact drug, strength and quantity.
- 3You choose and pay the pharmacy
You compare the responses, pick a pharmacy, and pay that pharmacy directly when you collect. Script Unlock never takes a patient payment and never sets the price.
Questions to ask your pharmacist about Estradiol
- 1.Does my product’s label still have the boxed warning?
- 2.Do I need a progestogen with my estradiol?
- 3.Where do I apply my patch or gel, and what do I do if a patch falls off?
- 4.Which signs of a blood clot, stroke or abnormal bleeding need urgent care?
Where Estradiol fits
Related medications
Sources
- FDA-approved labeling on DailyMed (estradiol)
- FDA, approval of labeling changes to six menopausal hormone therapy products (February 12, 2026)
- FDA, menopausal hormone therapies with updated prescribing information (Prometrium, Divigel, Cenestin, Enjuvia, Estring, Bijuva)
- FDA, announcement that boxed warning statements would be removed from hormone replacement therapy labels (November 10, 2025)
- Drugs@FDA, Divigel labeling approval letter (NDA 022038, supplement 17), February 12, 2026
- Drugs@FDA, Estring labeling approval letter (NDA 020472, supplement 22), February 12, 2026
- Drugs@FDA, Bijuva labeling approval letter (NDA 210132, supplement 13), February 12, 2026
- DailyMed, Divigel (estradiol gel) prescribing information, revised February 2026
- Estring (estradiol vaginal system) label, revised February 2026, with no boxed warning (Drugs@FDA)
- DailyMed, Bijuva (estradiol and progesterone) capsules, boxed warning removed February 2026
- DailyMed, estradiol tablets (Teva) prescribing information
- DailyMed, Climara (estradiol transdermal system) prescribing information
- Climara and Menostar prescribing information (Drugs@FDA, 2024)
- DailyMed, Vivelle-Dot (estradiol transdermal system) prescribing information
- EstroGel (estradiol gel) label, revised May 2026 (Drugs@FDA)
- Elestrin (estradiol gel) label (Drugs@FDA, 2024)
- DailyMed, Evamist (estradiol transdermal spray) prescribing information
- DailyMed, Estrace (estradiol vaginal cream) prescribing information
- DailyMed, Vagifem (estradiol vaginal inserts) prescribing information
- DailyMed, Femring (estradiol acetate vaginal ring) prescribing information
- MedlinePlus drug information (National Library of Medicine)
- MedlinePlus, estrogen
- MedlinePlus, estradiol transdermal patch
- MedlinePlus, estradiol topical (gel and spray)
- MedlinePlus, estrogen vaginal
- FDA Orange Book (approved generics and therapeutic equivalence)
- Drugs@FDA, Estrace 1 mg tablets (ANDA 084499): discontinued
- Orange Book, Estrace 2 mg tablets (ANDA 084500): discontinued
- Drugs@FDA, Divigel (NDA 022038) and rated generics
- Drugs@FDA, Estrace vaginal cream (ANDA 086069) and rated generics
- Drugs@FDA, Climara and Menostar patches (NDA 020375)
- Drugs@FDA, Alora patches (NDA 020655): discontinued
Script Unlock is a marketplace that lets licensed pharmacies quote a cash price on your prescription. It does not prescribe, dispense or sell medication, does not process patient payments, and does not give medical advice. Always follow the instructions of your prescriber and pharmacist and read the medication guide supplied with your medicine.